A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis

NCT03997786 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate-to-severe Chronic Plaque Psoriasis

Interventions

DRUG: Tildrakizumab
DRUG: Placebo
DRUG: Tildrakizumab
DRUG: Tildrakizumab
DRUG: Tildrakizumab
DRUG: Etanercept
DRUG: Placebo

Sponsor

Sun Pharmaceutical Industries Limited